☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
co-development
Coave Signs an Exclusive License Agreement with Théa to Co-Development and Commercialize CTx-PDE6b for PDE6b Associated Retinitis...
September 17, 2021
Eisai Collaborates with BMS for the Co-Development and Co-Commercialization of MORAb-202
June 21, 2021
Onward Signs a Worldwide Exclusive License and Co-Development Agreement with Biomunex for Immuno-Oncology
February 16, 2021
Oncolytics Biotech Signs a Clinical Trial Collaboration with Merck KGaA and Pfizer
June 6, 2019
BeiGene Signs a Worldwide Co-Development and Commercialization Agreement with BioAtla for BA3071 and Tislelizumab
April 9, 2019
Takeda Globally Signs Licensing- Co-Development & Co-Promotion Agreement with Enterome for its EB8018 Candidate
October 24, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.